title: Treatment of cutaneous T cell lymphoma stage II with interferon-alpha-2a and extracorporeal photochemotherapy: a prospective controlled trial.
authors.affiliation: Department of Dermatology and Allergology, Friedrich Schiller University of Jena, Germany. Wollina-Uw@khdf.de
authors.forename: U
authors.initials: U
authors.lastname: Wollina
authors.forename: A
authors.initials: A
authors.lastname: Looks
authors.forename: J
authors.initials: J
authors.lastname: Meyer
authors.forename: B
authors.initials: B
authors.lastname: Knopf
authors.forename: H J
authors.initials: HJ
authors.lastname: Koch
authors.forename: K
authors.initials: K
authors.lastname: Liebold
authors.forename: U C
authors.initials: UC
authors.lastname: Hipler
mesh_terms: D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D004890:Erythema / Q000175:diagnosis; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000009:adverse effects / Q000627:therapeutic use*; D016410:Lymphoma, T-Cell, Cutaneous / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D017893:Photopheresis; D011994:Recombinant Proteins; D012878:Skin Neoplasms / Q000188:drug therapy*; D016896:Treatment Outcome
chemical_list: D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins